Gynae BT 2017

Reported severe morbidity IGABT

RetroEMBRACE: Late toxicity recorded in 610/731 patients. Actuarial rates of severe (G3-G5) at 5 years were:

•Bladder 5% •GI-tract 7% •Vagina 5%

Monocentric series MRI guided IGABT >100 patients (Vienna, Aarhus, Paris) report: 5.6% - 7% severe (G3-G5) morbidity

Sturdza et al. R&O 2016; Potter R&O 2011; Lindegaard Acta Onc 2013; Castelnau-Marchand Gyn Onc 2015